CY1124079T1 - Αποτελεσματικη επιλεκτικοτητα των ανασυνδυασμενων πρωτεϊνων - Google Patents
Αποτελεσματικη επιλεκτικοτητα των ανασυνδυασμενων πρωτεϊνωνInfo
- Publication number
- CY1124079T1 CY1124079T1 CY20211100104T CY211100104T CY1124079T1 CY 1124079 T1 CY1124079 T1 CY 1124079T1 CY 20211100104 T CY20211100104 T CY 20211100104T CY 211100104 T CY211100104 T CY 211100104T CY 1124079 T1 CY1124079 T1 CY 1124079T1
- Authority
- CY
- Cyprus
- Prior art keywords
- recombinant proteins
- expression
- mammalian
- well
- invention includes
- Prior art date
Links
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 title abstract 3
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 title abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 210000004962 mammalian cell Anatomy 0.000 abstract 2
- 239000003550 marker Substances 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000003886 Glycoproteins Human genes 0.000 abstract 1
- 108090000288 Glycoproteins Proteins 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000004481 post-translational protein modification Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462039416P | 2014-08-19 | 2014-08-19 | |
| PCT/US2015/045793 WO2016028838A1 (en) | 2014-08-19 | 2015-08-19 | Efficient selectivity of recombinant proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1124079T1 true CY1124079T1 (el) | 2022-05-27 |
Family
ID=55347784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20211100104T CY1124079T1 (el) | 2014-08-19 | 2021-02-08 | Αποτελεσματικη επιλεκτικοτητα των ανασυνδυασμενων πρωτεϊνων |
Country Status (27)
| Country | Link |
|---|---|
| US (4) | US9732357B2 (enExample) |
| EP (2) | EP3183359B1 (enExample) |
| JP (4) | JP7115851B2 (enExample) |
| KR (2) | KR102556383B1 (enExample) |
| CN (2) | CN113293139B (enExample) |
| AR (1) | AR102333A1 (enExample) |
| AU (3) | AU2015305565B9 (enExample) |
| CA (1) | CA2957036A1 (enExample) |
| CY (1) | CY1124079T1 (enExample) |
| DK (1) | DK3183359T3 (enExample) |
| EA (1) | EA035340B1 (enExample) |
| ES (1) | ES2849728T3 (enExample) |
| HR (1) | HRP20210301T1 (enExample) |
| HU (1) | HUE054069T2 (enExample) |
| IL (3) | IL287020B (enExample) |
| LT (1) | LT3183359T (enExample) |
| MA (1) | MA40371B1 (enExample) |
| MX (2) | MX384990B (enExample) |
| MY (1) | MY191745A (enExample) |
| PL (1) | PL3183359T3 (enExample) |
| PT (1) | PT3183359T (enExample) |
| RS (1) | RS61371B1 (enExample) |
| SG (2) | SG11201701121UA (enExample) |
| SI (1) | SI3183359T1 (enExample) |
| SM (1) | SMT202100054T1 (enExample) |
| TW (3) | TWI832364B (enExample) |
| WO (1) | WO2016028838A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR102333A1 (es) | 2014-08-19 | 2017-02-22 | Regeneron Pharma | Selectividad eficiente de proteínas recombinadas |
| WO2019157395A1 (en) | 2018-02-08 | 2019-08-15 | Applied Stemcells, Inc | Methods for screening variant of target gene |
| CN114585597A (zh) | 2019-10-23 | 2022-06-03 | 佳能株式会社 | 制造陶瓷制品的方法和陶瓷制品 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4634665A (en) | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4656134A (en) | 1982-01-11 | 1987-04-07 | Board Of Trustees Of Leland Stanford Jr. University | Gene amplification in eukaryotic cells |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US6077835A (en) | 1994-03-23 | 2000-06-20 | Case Western Reserve University | Delivery of compacted nucleic acid to cells |
| KR970029803A (ko) | 1995-11-03 | 1997-06-26 | 김광호 | 반도체 메모리장치의 프리차지 회로 |
| US5972650A (en) | 1997-06-26 | 1999-10-26 | Brigham And Women's Hospital | Tetracycline repressor regulated mammalian cell transcription and viral replication switch |
| US6281005B1 (en) | 1999-05-14 | 2001-08-28 | Copernicus Therapeutics, Inc. | Automated nucleic acid compaction device |
| WO2001053312A1 (en) * | 1999-12-23 | 2001-07-26 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
| EP1392859B1 (en) | 2001-01-16 | 2006-05-10 | Regeneron Pharmaceuticals, Inc. | Isolating cells expressing secreted proteins |
| US7192737B2 (en) | 2002-03-29 | 2007-03-20 | Xoma Technology Ltd. | Methods and materials for increasing expression of recombinant polypeptides |
| US8673589B2 (en) | 2002-05-29 | 2014-03-18 | Regeneron Pharmaceuticals, Inc. | Inducible eukaryotic expression system |
| US7384744B2 (en) * | 2002-11-29 | 2008-06-10 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such products |
| JP2005027599A (ja) | 2003-07-09 | 2005-02-03 | Nara Institute Of Science & Technology | 植物由来遺伝子を用いた遺伝子導入植物の選抜法 |
| EP1586585A1 (de) * | 2004-04-14 | 2005-10-19 | F. Hoffmann-La Roche Ag | Expressionssystem zur Herstellung von IL-15/Fc-Fusionsproteinen und ihre Verwendung |
| AR064200A1 (es) | 2006-12-07 | 2009-03-18 | Dow Agrosciences Llc | Genes marcadores seleccionables |
| ES2522615T3 (es) | 2007-06-04 | 2014-11-17 | Regeneron Pharmaceuticals, Inc. | Regiones de expresión y estabilidad potenciadas |
| KR100927803B1 (ko) * | 2007-11-23 | 2009-11-23 | 한국생명공학연구원 | 식물 형질전환체를 선별하기 위한 마커로서 ｇｐｔ 유전자 |
| ES2570853T3 (es) * | 2007-12-07 | 2016-05-20 | Zymogenetics Inc | Moléculas de anticuerpo humanizadas específicas para IL-31 |
| US20110091495A1 (en) * | 2008-04-22 | 2011-04-21 | Rutgers, The State University Of New Jersey | Hcv e2 construct compositions and methods |
| US8927249B2 (en) * | 2008-12-09 | 2015-01-06 | Halozyme, Inc. | Extended soluble PH20 polypeptides and uses thereof |
| EP2674495A1 (en) | 2012-06-14 | 2013-12-18 | Sanofi | CHO expression system |
| AR102333A1 (es) | 2014-08-19 | 2017-02-22 | Regeneron Pharma | Selectividad eficiente de proteínas recombinadas |
-
2015
- 2015-08-14 AR ARP150102631A patent/AR102333A1/es active IP Right Grant
- 2015-08-17 TW TW111129504A patent/TWI832364B/zh active
- 2015-08-17 TW TW104126657A patent/TWI719945B/zh active
- 2015-08-17 TW TW110101888A patent/TWI777374B/zh active
- 2015-08-19 CN CN202110402963.4A patent/CN113293139B/zh active Active
- 2015-08-19 AU AU2015305565A patent/AU2015305565B9/en active Active
- 2015-08-19 SG SG11201701121UA patent/SG11201701121UA/en unknown
- 2015-08-19 HU HUE15833421A patent/HUE054069T2/hu unknown
- 2015-08-19 EA EA201790241A patent/EA035340B1/ru unknown
- 2015-08-19 PL PL15833421T patent/PL3183359T3/pl unknown
- 2015-08-19 MY MYPI2017700248A patent/MY191745A/en unknown
- 2015-08-19 RS RS20210103A patent/RS61371B1/sr unknown
- 2015-08-19 US US14/829,834 patent/US9732357B2/en active Active
- 2015-08-19 WO PCT/US2015/045793 patent/WO2016028838A1/en not_active Ceased
- 2015-08-19 CA CA2957036A patent/CA2957036A1/en active Pending
- 2015-08-19 EP EP15833421.9A patent/EP3183359B1/en active Active
- 2015-08-19 LT LTEP15833421.9T patent/LT3183359T/lt unknown
- 2015-08-19 JP JP2017509733A patent/JP7115851B2/ja active Active
- 2015-08-19 KR KR1020227018877A patent/KR102556383B1/ko active Active
- 2015-08-19 SI SI201531487T patent/SI3183359T1/sl unknown
- 2015-08-19 SG SG10201707859RA patent/SG10201707859RA/en unknown
- 2015-08-19 IL IL287020A patent/IL287020B/en unknown
- 2015-08-19 MX MX2017002203A patent/MX384990B/es unknown
- 2015-08-19 CN CN201580044100.7A patent/CN107075549B/zh active Active
- 2015-08-19 SM SM20210054T patent/SMT202100054T1/it unknown
- 2015-08-19 HR HRP20210301TT patent/HRP20210301T1/hr unknown
- 2015-08-19 PT PT158334219T patent/PT3183359T/pt unknown
- 2015-08-19 DK DK15833421.9T patent/DK3183359T3/da active
- 2015-08-19 ES ES15833421T patent/ES2849728T3/es active Active
- 2015-08-19 KR KR1020177006620A patent/KR102406976B1/ko active Active
- 2015-08-19 EP EP20211902.0A patent/EP3901274A1/en active Pending
- 2015-08-19 MA MA40371A patent/MA40371B1/fr unknown
-
2017
- 2017-02-09 IL IL250531A patent/IL250531B/en unknown
- 2017-02-17 MX MX2021009154A patent/MX2021009154A/es unknown
- 2017-07-31 US US15/664,444 patent/US10457959B2/en active Active
-
2019
- 2019-09-10 US US16/566,253 patent/US11085053B2/en active Active
-
2020
- 2020-07-17 AU AU2020205336A patent/AU2020205336B2/en active Active
- 2020-08-05 JP JP2020132874A patent/JP7260510B2/ja active Active
-
2021
- 2021-02-08 CY CY20211100104T patent/CY1124079T1/el unknown
- 2021-07-02 US US17/366,239 patent/US20210340564A1/en not_active Abandoned
-
2022
- 2022-08-04 IL IL295361A patent/IL295361B2/en unknown
-
2023
- 2023-02-10 AU AU2023200752A patent/AU2023200752B2/en active Active
- 2023-04-06 JP JP2023061971A patent/JP7561232B2/ja active Active
-
2024
- 2024-09-20 JP JP2024163845A patent/JP2024166420A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1125392T1 (el) | Συνθεσεις και μεθοδοι γλυζυλιωσης πρωτεϊνων | |
| PH12018500252A1 (en) | Factor ix fusion protiens and methods of making and using same | |
| MX2022013540A (es) | Constructos de expresion y metodos para dise?ar geneticamente levadura metilotrofica. | |
| CR20170282A (es) | Nuevos péptidos y nueva combinación de péptidos para el uso en la inmunoterapia contra el carcinoma hepatocelular (chc) y otros tipos de cáncer | |
| BR112019007288A2 (pt) | proteína heterodimérica biespecífica, composições de ácido nucleico e de vetor de expressão, vetor de expressão, célula hospedeira, e, métodos para produzir proteína heterodimérica biespecífica e para tratar câncer em um paciente | |
| BR112017025564B8 (pt) | Anticorpos anti-ctla-4 e métodos de uso dos mesmos | |
| PH12018501280A1 (en) | Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use | |
| MX2017014908A (es) | Proteinas de union triespecificas y metodos de uso. | |
| MX2019006043A (es) | Proteína de unión de antígeno prostático específico de membrana. | |
| MX2017005774A (es) | Anticuerpos antimiostatina, polipeptidos que contienen regiones fc variantes, y metodos de uso. | |
| CY1124727T1 (el) | Πρωτεϊνες συντηξης tatk-cdkl5, συνθεσεις, φαρμακοτεχνικες μορφες και η χρηση αυτων | |
| MX375524B (es) | Anticuerpos anti-axl. | |
| JOP20210010A1 (ar) | بروتينات مخصصة ل baff و b7rp1 وإستخداماتها | |
| MX2015014424A (es) | Construcciones de proteinas mitocondriales y sus usos. | |
| EA201791918A1 (ru) | Модификация белков клеток-хозяев | |
| EA201691532A1 (ru) | Сверхэкспрессия регуляторов пути n-гликозилирования для модуляции гликозилирования рекомбинантных белков | |
| CY1124079T1 (el) | Αποτελεσματικη επιλεκτικοτητα των ανασυνδυασμενων πρωτεϊνων | |
| MX2024000004A (es) | Proteinas de fusion de inhibidor de tripsina urinaria (uti). | |
| EA201892085A1 (ru) | Новые белки, полученные из альфа-1-микроглобулина, и их применение |